抗血小板药物在卒中预防中的应用。
Platelet antiaggregants in stroke prevention.
机构信息
Neurology Department, Stritch School of Medicine, Loyola University Chicago, 2160 South 1st Avenue, Building 105, Room 2700, Maywood, IL 60153, USA.
出版信息
Neurol Clin. 2013 Aug;31(3):633-57. doi: 10.1016/j.ncl.2013.03.004. Epub 2013 Jun 20.
PMID:23896497
Abstract
Antiplatelet agents are one of the main interventions for recurrent ischemic stroke prevention. Their time of use, dosage, and combination of therapy have different effects in terms of stroke risk reduction and adverse effects. This review provides an evidence-based update of the latest on antiplatelet therapy for stroke prevention.
摘要
抗血小板药物是预防复发性缺血性卒中的主要干预措施之一。其使用时间、剂量和联合治疗方案对降低卒中风险和不良反应的效果不同。本综述提供了抗血小板治疗预防卒中的最新循证更新。
Zotero 插件